Stock listing

Oric Pharmaceuticals, Inc.

Selected listing: 4TZ · DUS · EUR · DE

Oric Pharmaceuticals, Inc. (Dusseldorf:4TZ), Health Technology. Latest release Oct 5, 2026: ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK…

4TZ:DUSEURDEUpdated October 2, 2026

Ticker: Dusseldorf:4TZ
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Dusseldorf
Currency: EUR

Latest news from Oric Pharmaceuticals, Inc.

ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

October 5, 2026

ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development

October 4, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

October 2, 2026

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

October 1, 2026

ORIC® Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Updates

August 3, 2026

All Oric Pharmaceuticals, Inc. news →

Events

Replays

Oric Pharmaceuticals, Inc. (ORIC) Q4 2021 Earnings Call
Mon, Mar 21, 2022 · 05:00 PM ET
Watch

Research Oric Pharmaceuticals, Inc.

Oric Pharmaceuticals, Inc. company profile

View the public company page for Oric Pharmaceuticals, Inc. on 6ix.

Oric Pharmaceuticals, Inc. news

Read company news and market updates connected to Oric Pharmaceuticals, Inc..

Oric Pharmaceuticals, Inc. investor events

Find investor webinars, events, and replay context for Oric Pharmaceuticals, Inc..